| Dr Arisa Takeuchi, MD | |
|
95-1249 Meheula Pkwy Ste 187, Mililani, HI 96789-1791 | |
| (808) 625-6444 | |
| (808) 623-2552 |
| Full Name | Dr Arisa Takeuchi |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 95-1249 Meheula Pkwy Ste 187, Mililani, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235625435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-23529 (Hawaii) | Primary |
| Entity Name | Straub Clinic & Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.
The Detroit News: On Wednesday, "[a] federal judge heard arguments [in the] lawsuit that is being watched nationwide for its challenge of congressional authority to reform health care in a way that would penalize citizens who fail to obtain their own health insurance." The attorney for one plaintiff, The Thomas More Law Center, a group espousing religious principles, said, "There is no precedent for this power grab" (Guthrie, 7/22).
In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center.
The New York Times and the Financial Times examine concerns expressed by AIDS activists and members of an FDA panel that last week recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arisa Takeuchi, MD 95-1249 Meheula Pkwy Ste 187, Mililani, HI 96789-1791 Ph: (808) 625-6444 | Dr Arisa Takeuchi, MD 95-1249 Meheula Pkwy Ste 187, Mililani, HI 96789-1791 Ph: (808) 625-6444 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.
The Detroit News: On Wednesday, "[a] federal judge heard arguments [in the] lawsuit that is being watched nationwide for its challenge of congressional authority to reform health care in a way that would penalize citizens who fail to obtain their own health insurance." The attorney for one plaintiff, The Thomas More Law Center, a group espousing religious principles, said, "There is no precedent for this power grab" (Guthrie, 7/22).
In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center.
The New York Times and the Financial Times examine concerns expressed by AIDS activists and members of an FDA panel that last week recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus.
› Verified 9 days ago
Dr. Corey C Chinn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 95-390 Kuahelani Ave, Mililani, HI 96789 Phone: 808-586-2890 | |
Anna Tamai, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 95-390 Kuahelani Avenue, The Physician Center, Mililani, HI 96789 Phone: 808-627-3230 | |
Kana Maeji, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 95-390 Kuahelani Ave, Mililani, HI 96789 Phone: 808-627-3255 | |
Dr. Steven A Hankins, M.D., M.P.H., M.T.S. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 95-390 Kuahelani Ave, Physician Center Mililani, Mililani, HI 96789 Phone: 808-627-3200 Fax: 808-627-3262 | |
Nataliya V Holmes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 95-1249 Meheula Pkwy, Mililani, HI 96789 Phone: 808-625-6444 | |
Dr. Melanie Moanikeala Payanal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 95-390 Kuahelani Ave, Mililani, HI 96789 Phone: 808-627-3230 | |
Dr. Carrie Suzanne Marshall, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 95-390 Kuahelani Ave, Mililani, HI 96789 Phone: 808-627-3230 |